GALECTIN THERAPEUTICS INC. Operating Leases, Rent Expense
GALECTIN THERAPEUTICS INC. (GALT) reported Operating Leases, Rent Expense of $55.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-03-06
- GALECTIN THERAPEUTICS INC. operating leases, rent expense for fiscal 2018 was $55.00K, a 12.24% increase from fiscal 2017.
- GALECTIN THERAPEUTICS INC. operating leases, rent expense for fiscal 2017 was $49.00K, a 2.00% decline from fiscal 2016.
- GALECTIN THERAPEUTICS INC. operating leases, rent expense for fiscal 2016 was $50.00K, a 6.38% increase from fiscal 2015.
- GALECTIN THERAPEUTICS INC. operating leases, rent expense for fiscal 2015 was $47.00K, a 6.82% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 1 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|
| 2018-12-31 | $55.00K 10-K · filed 2019-03-06 | ||
| 2017-12-31 | $49.00K 10-K · filed 2019-03-06 | ||
| 2016-12-31 | $50.00K 10-K · filed 2018-03-29 | ||
| 2015-12-31 | $47.00K 10-K · filed 2017-03-28 | ||
| 2014-12-31 | $44.00K 10-K · filed 2016-03-15 | ||
| 2013-12-31 | $39.00K 10-K · filed 2016-03-15 | $36.00K 10-K · filed 2014-03-21 | |
| 2012-12-31 | $216.00K 10-K · filed 2014-03-21 | ||
| 2012-08-31 | $44.00K 10-K · filed 2013-03-29 | ||
| 2011-12-31 | $293.00K 10-K · filed 2013-03-29 | ||
| 2011-07-31 | $44.00K 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |